Eyecare Associates - Medicare Optometrist in Midvale, UT

Eyecare Associates is a medicare enrolled "Optometrist" provider in Midvale, Utah. Their current practice location is 7400 Union Park Ave, Suite 202, Midvale, Utah. You can reach out to their office (for appointments etc.) via phone at (801) 569-3698.

Eyecare Associates is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Eyecare Associates is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1649477514.

Contact Information

Eyecare Associates
7400 Union Park Ave, Suite 202,
Midvale, UT 84047-6704
(801) 569-3698
(801) 569-0578



Healthcare Provider's Profile

Full NameEyecare Associates
TypeFacility
SpecialityOptometrist
Location7400 Union Park Ave, Midvale, Utah
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1649477514
  • Provider Enumeration Date: 07/02/2007
  • Last Update Date: 10/10/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 9537064456
  • Enrollment ID: O20031204000304

Medical Identifiers

Medical identifiers for Eyecare Associates such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1649477514NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Eyecare Associates acts as a billing entity for following providers:
Provider NameKris Alfred Hill
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1043228554
PECOS PAC ID: 9335044262
Enrollment ID: I20031215000520

News Archive

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy, and their combinations.

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

U.S. population largely unaware of cancer drug shortages, study finds

The U.S. population is largely unaware that there are shortages in the availability of cancer drugs, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more Medical News

› Verified 3 days ago

Provider NameAngela Hill
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1982613865
PECOS PAC ID: 3577532944
Enrollment ID: I20041001000430

News Archive

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy, and their combinations.

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

U.S. population largely unaware of cancer drug shortages, study finds

The U.S. population is largely unaware that there are shortages in the availability of cancer drugs, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more Medical News

› Verified 3 days ago

Provider NameDean Brown
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1821051400
PECOS PAC ID: 6406916261
Enrollment ID: I20161108001088

News Archive

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy, and their combinations.

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

U.S. population largely unaware of cancer drug shortages, study finds

The U.S. population is largely unaware that there are shortages in the availability of cancer drugs, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more Medical News

› Verified 3 days ago

Provider NameJedidiah David Smith
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1649603572
PECOS PAC ID: 9537408570
Enrollment ID: I20190308000971

News Archive

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy, and their combinations.

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

U.S. population largely unaware of cancer drug shortages, study finds

The U.S. population is largely unaware that there are shortages in the availability of cancer drugs, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eyecare Associates is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eyecare Associates
7400 Union Park Ave, Suite 202,
Midvale, UT 84047-6704

Ph: (801) 569-3698
Eyecare Associates
7400 Union Park Ave, Suite 202,
Midvale, UT 84047-6704

Ph: (801) 569-3698

News Archive

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy, and their combinations.

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

U.S. population largely unaware of cancer drug shortages, study finds

The U.S. population is largely unaware that there are shortages in the availability of cancer drugs, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more News

› Verified 3 days ago


Optometrist in Midvale, UT

Dr. Roland Espeleta Abundo, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 579 Fort Union Blvd, Midvale, UT 84047
Phone: 801-255-8500    Fax: 801-255-2334
Dr. Kris Alfred Hill, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 7400 Union Park Ave, Suite 202, Midvale, UT 84047
Phone: 801-569-3698    
Dr. Craig M Smith, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 7495 S State St, Midvale, UT 84047
Phone: 801-213-9400    Fax: 801-213-9443
Dr. Stephen K Martin, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 22 W. 7200 S., Midvale, UT 84047
Phone: 801-561-1300    
Eye Care 4 Kids
Optometrist
Medicare: Medicare Enrolled
Practice Location: 6911 S State St, Midvale, UT 84047
Phone: 801-255-8525    Fax: 801-255-8526
Dr. David Jaeson Potter, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 20 W 7200 S, Midvale, UT 84047
Phone: 801-561-1300    
Uuhc Greenwood Clinic
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7495 S State St, Midvale, UT 84047
Phone: 801-213-9400    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.